Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.3100 (0.11%) ($101.3100 - $101.3100) on Mon. Feb. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.63% (three month average) | RSI | 29 | Latest Price | $101.3100(0.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -9.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWO(62%) IBB(61%) IWM(60%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.815% in a week (0% probabilities). VIXM(-27%) UUP(-20%) VXX(-17%) EDOC(-8%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.815% (StdDev 3.63%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $88.1(-13.04%) | Resistance Level | $114.55 | 5 Day Moving Average | $99.97(1.34%) | 10 Day Moving Average | $107.63(-5.87%) | 20 Day Moving Average | $114.55(-11.56%) | To recent high | -37.8% | To recent low | 6.2% | Market Cap | $1.628b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |